Ignite Creation Date:
2024-05-05 @ 11:46 AM
Last Modification Date:
2024-10-26 @ 9:12 AM
Study NCT ID:
NCT00122421
Status:
COMPLETED
Last Update Posted:
2012-02-20
First Post:
2005-07-19
Brief Title:
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
Sponsor:
Brigham and Womens Hospital
Organization:
Brigham and Womens Hospital
Study Overview
Official Title:
The Impact of Pharmacist Recommendations on Quality of Care in Diabetic Patients
Status:
COMPLETED
Status Verified Date:
2012-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The goal of this study is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Womens Hospital This will be accomplished through pharmacist recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients
Detailed Description:
Type II diabetes mellitus is an increasingly common condition among adults in the United States and is associated with substantial morbidity and mortality The microvascular and macrovascular complications of diabetes lead to significant disability and early mortality in addition to tremendous costs to the healthcare system It has been clearly demonstrated that both microvascular and macrovascular complications can be reduced through specific interventions that can be carried out by office-based primary care physicians Despite the accumulation of evidence regarding specific interventions that can reduce diabetes-related morbidity and mortality multiple studies have shown that the care provided for diabetic patients frequently falls short of recommended standards
The researchers goal is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Womens Hospital This will be accomplished through pharmacist-delivered recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients
Adult diabetic patients age 18 years and older receiving primary care in the Brigham Internal Medicine Associates BIMA practice will be randomized to intervention and control groups based on the practice subset Suite within BIMA in which they receive their ongoing care Patients who receive care from providers in Suites A B E and F will be assigned to the intervention group while patients who receive care from providers in Suites C D G and H will be assigned to the control group Patients will not be contacted regarding the study providers who practice in the intervention Suites will receive specific written recommendations regarding optimal diabetes care parameters from our study pharmacist prior to each patients visit Providers who practice in the control Suites will not be contacted Pre- and post-intervention compliance with multiple diabetes quality-of-care measures eg Hemoglobin A1c measurement LDL cholesterol measurement pneumococcal vaccination etc will be assessed in the intervention and control groups
The researchers goal is to investigate a comprehensive provider-focused intervention to improve the quality of care for diabetic patients in a large primary care practice at Brigham and Womens Hospital This will be accomplished through pharmacist-delivered recommendations provided to primary care providers prior to routine scheduled office visits for diabetic patients
Adult diabetic patients age 18 years and older receiving primary care in the Brigham Internal Medicine Associates BIMA practice will be randomized to intervention and control groups based on the practice subset Suite within BIMA in which they receive their ongoing care Patients who receive care from providers in Suites A B E and F will be assigned to the intervention group while patients who receive care from providers in Suites C D G and H will be assigned to the control group Patients will not be contacted regarding the study providers who practice in the intervention Suites will receive specific written recommendations regarding optimal diabetes care parameters from our study pharmacist prior to each patients visit Providers who practice in the control Suites will not be contacted Pre- and post-intervention compliance with multiple diabetes quality-of-care measures eg Hemoglobin A1c measurement LDL cholesterol measurement pneumococcal vaccination etc will be assessed in the intervention and control groups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None